Computational characterization of peptide binding stability to HLA-C allotypes and its association with HIV-1 infection progression and HIV-1 related neurocognitive impairment

计算表征肽与HLA-C同种异型结合稳定性及其与HIV-1感染进展和HIV-1相关神经认知障碍的关系

阅读:4

Abstract

BACKGROUND: HLA-C molecules play a critical role in the immune response, particularly in antigen presentation and immune modulation. METHODS: To investigate the effect of the most common HLA-C allotypes on the stability of the HLA-C-β-2 microglobulin-peptide complex, we used the NetMHCpan-4.2 bioinformatic tool that predicts peptide binding to MHC class I molecules. This allowed us to predict the probability of a broad set of peptides to be naturally processed, presented on each HLA-C allotype, and ultimately recognised by the immune system, measured by EL-score. By plotting the EL-score against the percentile of the peptide's stability rank position, curves were drawn to illustrate the relative stability of the binding interaction of each HLA-C allotype tested, and the area under the curve was calculated to determine a stability score for each HLA-C variant. RESULTS: This approach permits us to greatly improve the classification of HLA-C allotypes according to their stability, overcoming the previous coarse stable and unstable binary classification. Analysis of two well-characterised HIV-1 patient cohorts, one focused on disease progression and the other on neurocognitive impairment, demonstrated a significant association between unstable HLA-C alleles, faster disease progression, and worse HIV-associated neurocognitive outcomes. CONCLUSIONS: These findings underscore the role of HLA-C stability in AIDS progression, suggesting that profiling HLA-C stability may serve as a predictive tool for HIV-1 disease management and assessing neurocognitive risk, with potential implications in personalised medicine.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。